Janet Xiao, Ph.D.

Patent counsel to Genentech, a globalbiotechnology company that specializes in the discovery, development, and commercialization of innovative medicines for patients with serious or life-threatening medical.

Patent counsel to SNIPR Biome, a company pioneering CRISPR-based microbial gene therapy, since its inception to build and defend its extensive patent portfolio.

Patent counsel to Abraxis Biosciences, a global nano-medicine company wholly owned by Bristol-Myers Squibb working on groundbreaking cancer fighting drugs.

Patent counsel to CG Oncology, a clinical-stage biotechnology company pioneering the next evolution of oncolytic virus-based cancer therapies for patients with advanced cancer.

Patent counsel to Proteologix, a biotechnology company developing bispecific antibodies for immune-mediated diseases, which was recently acquired by Johnson & Johnson for $850 million in cash with potential for an additional milestone payment.